QiMing granules for diabetic retinopathy: a systematic review and meta-analysis of randomized controlled trials.
Ontology highlight
ABSTRACT: This study aimed to assess the efficacy and safety of QiMing granules (QM) in the treatment of patients with diabetic retinopathy (DR). We systematically searched multiple databases, including Pubmed, Embase, Web of Science, Cochrane Library, SinoMed, Chinese National Knowledge Infrastructure (CNKI), Wanfang database, and VIP database. Randomized controlled trials (RCTs) of QM in the treatment of DR were collected, and the search time limit was from the establishment of the database to 27 March 2024. Two independent researchers were involved in literature screening, data extraction, and bias risk assessment. The risk of bias in the included studies was assessed using the Risk of Bias Assessment tool for randomized controlled trials of Cochrane Collaboration 2.0 (RoB 2.0). The main outcomes
SUBMITTER: Zhang Y
PROVIDER: S-EPMC11374745 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA